HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sustained intraocular rapamycin delivery effectively prevents high-risk corneal allograft rejection and neovascularization in rabbits.

AbstractPURPOSE:
To evaluate the immunosuppressive and antiangiogenic activities of an intraocular rapamycin (RAPA) drug delivery system (DDS) in a rabbit model of high-risk penetrating keratoplasty.
METHODS:
Forty New Zealand White rabbits with corneal neovascularization underwent allograft cornea transplantation and were randomly divided into four groups: a control group, a glycolide-co-lactide-co-caprolactone copolymer (PGLC)-implanted group, a RAPA eye drop group, and a RAPA-PGLC DDS-implanted group. Graft survival, corneal neovascularization, and RAPA concentration in the aqueous humor were monitored for 90 days. Corneal grafts were also examined by in situ hybridization and immunohistochemistry for proinflammatory gene expression.
RESULTS:
In the control and PGLC groups, graft rejection occurred within 3 weeks of keratoplasty. In the RAPA eye drop and RAPA-PGLC groups, corneal rejection was significantly delayed, and neovascularization was markedly inhibited. Median graft survival times were 36 and >90 days in the eye drop and RAPA-PGLC groups, respectively. Mean RAPA concentrations in the aqueous humor were 10.7 ng/mL, 12.0 ng/mL, 9.2 ng/mL, and 7.0 ng/mL in the RAPA-PGLC group 2, 4, 8, and 12 weeks after surgery, respectively. By contrast, RAPA was undetectable in the aqueous humor in the eye drop group. High levels of IL-2R, MCP-1, TNF-alpha, and VEGF were detected in the corneal grafts of the control and PGLC groups but not in those of the RAPA-treated groups.
CONCLUSIONS:
RAPA-PGLC DDS and RAPA eye drops can significantly prolong the survival of allografts at high risk and inhibit corneal neovascularization. However, RAPA-PGLC DDS is far more effective than RAPA eye drops in preventing corneal graft rejection.
AuthorsWeiyun Shi, Hua Gao, Lixin Xie, Shenguo Wang
JournalInvestigative ophthalmology & visual science (Invest Ophthalmol Vis Sci) Vol. 47 Issue 8 Pg. 3339-44 (Aug 2006) ISSN: 0146-0404 [Print] United States
PMID16877400 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Chemokine CCL2
  • Immunosuppressive Agents
  • Polyesters
  • Receptors, Interleukin-2
  • Tumor Necrosis Factor-alpha
  • Vascular Endothelial Growth Factor A
  • poly(glycolide-co-lactide-co-caprolactone)
  • Sirolimus
Topics
  • Animals
  • Chemokine CCL2 (metabolism)
  • Corneal Neovascularization (metabolism, prevention & control)
  • Drug Delivery Systems
  • Graft Rejection (metabolism, prevention & control)
  • Graft Survival
  • Immunosuppressive Agents (administration & dosage)
  • In Situ Hybridization
  • Keratoplasty, Penetrating
  • Polyesters
  • Rabbits
  • Receptors, Interleukin-2 (metabolism)
  • Risk Factors
  • Sirolimus (administration & dosage)
  • Transplantation, Homologous
  • Tumor Necrosis Factor-alpha (metabolism)
  • Vascular Endothelial Growth Factor A (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: